Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Cambridge, MA
SEC filing record 1 source field available
Fiscal year end
31 December
CONSTELLATION PHARMACEUTICALS INC has filed 314 SEC EDGAR filings since 05 May 2008

SEC filing history

Showing 26-50 of 313 matching filings.

Per page
25
Current page
2
SC TO-T/A File 005-90572

SC TO-T/A

Filing date
06 Jul 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 14D9/A File 005-90572

SC 14D9/A

Filing date
06 Jul 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC TO-T/A File 005-90572

SC TO-T/A

Filing date
01 Jul 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 14D9/A File 005-90572

SC 14D9/A

Filing date
01 Jul 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC TO-T/A File 005-90572

SC TO-T/A

Filing date
01 Jul 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 14D9/A File 005-90572

SC 14D9/A

Filing date
01 Jul 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 14D9 File 005-90572

SC 14D9

Filing date
16 Jun 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC TO-T File 005-90572

SC TO-T

Filing date
16 Jun 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
04 Jun 2021
Reporting date
02 Jun 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
04 Jun 2021
Reporting date
02 Jun 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
04 Jun 2021
Reporting date
02 Jun 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
04 Jun 2021
Reporting date
02 Jun 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
04 Jun 2021
Reporting date
02 Jun 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
04 Jun 2021
Reporting date
02 Jun 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
SC14D9C File 005-90572

SC14D9C

Filing date
04 Jun 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC TO-C File 005-90572

SC TO-C

Filing date
02 Jun 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC14D9C File 005-90572

SC14D9C

Filing date
02 Jun 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-38584

DEFA14A

Filing date
23 Apr 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-38584

DEF 14A

Filing date
23 Apr 2021
Reporting date
02 Jun 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
CT ORDER File 333-225822

CT ORDER filing

Filing date
29 Mar 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
08 Mar 2021
Reporting date
04 Mar 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
5

PRIMARY DOCUMENT

Filing date
08 Mar 2021
Reporting date
31 Dec 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .